|
 |
| |
|
½ºÅ¸·¹º¸Çʸ§ÄÚÆÃÁ¤200/50/200mg Stalevo Film Coated Tab. 200/50/200mg
|
Àü¹®ÀǾàǰ | »èÁ¦
|
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ÁøÇÑ Àû°¥»öÀÇ Å¸¿øÇü Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
Novartis
|
ÆÇ¸Åȸ»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2008.05.27)
|
BIT ¾àÈ¿ºÐ·ù |
ÇׯÄŲ½¼Á¦ (Antiparkinsonian Agents)
|
º¹ÁöºÎºÐ·ù |
119[±âŸÀÇ ÁßÃ߽Űæ¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
653601410[E01631881] Àú°¡¾à ´ëü Àμ¾Æ¼ºê Áö±Þ ´ë»ó \0 ¿ø/1Á¤(2021.12.01)(ÇöÀç¾à°¡)\1,090 ¿ø/1Á¤(2020.01.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Levodopa, decarboxylase inhibitor and COMT inhibitor / N04BA03 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
±Û¸®¼¼¸°85%,
¹é´ç,
»êÈö(Àû»ö),
»êÈÆ¼Åº,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
¿Á¼ö¼öÀüºÐ,
Å©·Î½ºÄ«¸£¸á·Î¿À½º³ªÆ®·ý,
Æ÷ºñµ·,
Æú¸®¼Ò¸£º£ÀÌÆ® 80,
È÷ÇÁ·Î¸á·Î¿À½º,
D-¸¸´ÏÅç
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-04-09 |
|
|
|
|
| |
|
|
|